IP Library Patent Application 19036127
Patent Application
App. No. 19/036,127

COMPOSITIONS AND METHODS FOR LYOPHILIZATION OF BACTERIA OR LISTERIA STRAINS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/036,127
Abstract

Methods and compositions are provided for lyophilization of bacteria or Listeria strains, such as Listeria monocytogenes . Provided are methods for producing a lyophilized composition comprising a bacteria or Listeria strain, formulations for lyophilization comprising a bacteria or Listeria strain, lyophilized bacteria or Listeria strains, and methods of preparing frozen bacteria or Listeria strains for lyophilization.

Claims (15)

1 . A method of preparing a frozen Listeria strain for lyophilization, comprising thawing the frozen Listeria strain at a temperature between about 20° C. and about 37° C.

2 . The method of claim 1 , wherein the temperature is between about 32° C. and about 37° C.

3 . The method of claim 2 , wherein the temperature is about 37° C.

4 . The method of claim 1 , wherein the frozen Listeria strain is thawed for no more than 8 hours.

5 . The method of claim 1 , wherein the frozen Listeria strain is held at about 2° C. to about 8° C. for no more than 24 hours after thawing.

6 . The method of claim 1 , wherein the frozen Listeria strain is thawed in a formulation comprising a buffer and sucrose.

7 . The method of claim 6 , wherein the formulation comprises about 1% to about 5% w/v sucrose.

8 . The method of claim 7 , wherein the formulation comprises about 2% to about 3% w/v sucrose.

9 . The method of claim 8 , wherein the formulation comprises about 2.5% w/v sucrose.

10 . The method of claim 6 , wherein the formulation does not comprise one or more of trehalose, mono sodium glutamate (MSG), and recombinant human serum albumin (rHSA).

11 . The method of claim 10 , wherein the formulation does not comprise trehalose, MSG, or rHSA.

12 . The method of claim 6 , wherein the Listeria strain is a recombinant Listeria monocytogenes strain.

13 . The method of claim 6 , wherein the Listeria strain is a recombinant Listeria monocytogenes strain,

wherein the formulation comprises about 2% to about 3% w/v sucrose, and

wherein the formulation does not comprise trehalose, MSG, or rHSA.

Assignments (1)
CHANGE OF NAME Recorded Nov 20, 2025
From: ADVAXIS, INC.
To: AYALA PHARMACEUTICALS, INC.
Reel/Frame 073682/0045 →